Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2014
07/15/2014CA2782510C Polypeptides
07/15/2014CA2569200C Humanized anti-tag-72 monoclonal antibodies
07/15/2014CA2547126C Substance binding human igg fc receptor iib (fcyriib)
07/15/2014CA2526640C Immunogenic reagents from west nile virus
07/15/2014CA2526398C Human monoclonal antibodies against bacillus anthracis protective antigen
07/15/2014CA2496485C Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis
07/15/2014CA2457632C Identification and isolation of somatic stem cells and uses thereof
07/10/2014WO2014107739A1 Antibodies against pcsk9
07/10/2014WO2014107737A2 Local delivery of il-17 inhibitors for treating ocular disease
07/10/2014WO2014107599A2 Compositions and methods for detecting protease activity in biological systems
07/10/2014WO2014107269A1 Secretory iga compositions, methods of making and methods of use thereof
07/10/2014WO2014107165A1 Fully human antibodies against human receptor igf-1r
07/10/2014WO2014106602A1 Antibodies that bind to tl1a and their uses
07/10/2014WO2014106527A1 Method for producing secretable antibodies by expression in saccharomyces cerevisiae
07/10/2014WO2014052713A3 Her2-and vegf-a-binding proteins with enhanced stability
07/10/2014US20140196175 AXMI221z, AXMI222z, AXMI223z, AXMI224z and AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE
07/10/2014US20140194600 Use of anti-factor xi antibodies for prevention of thrombus formation
07/10/2014US20140194599 Anti-Human Interleukin-20 Antibodies
07/10/2014US20140194598 B7-related nucleic acids and polypeptides useful for immunomodulation
07/10/2014US20140194597 Modified chimeric polypeptides with improved pharmacokinetic properties
07/10/2014US20140194596 Dual Specificity Antibody Fusions
07/10/2014US20140193899 Monoclonal antibodies to fibroblast growth factor receptor 2
07/10/2014US20140193855 Methods and compositions for determining the purity of chemically synthesized nucleic acids
07/10/2014US20140193830 Optical biosensors
07/10/2014US20140193829 Monoclonal antibodies against scrapie prion protein
07/10/2014US20140193467 Compositions comprising tnf-specific antibodies for oral delivery
07/10/2014US20140193434 Pharmaceutical composition for treatment and/or prophylaxis of cancer
07/10/2014US20140193433 Bcma-based stratification and therapy for multiple myeloma patients
07/10/2014US20140193432 Anti-hdlk-1 antibody having an antitumor activity in vivo
07/10/2014US20140193431 Anti-c-met antibody having hgf activity and use thereof
07/10/2014US20140193430 Compositions and methods for regulating nk cell activity
07/10/2014US20140193429 Metal-citrate transporter antigen from streptomyces coelicolor and uses thereof
07/10/2014US20140193428 Human cytomegalovirus neutralizing antibodies and use thereof
07/10/2014US20140193427 Anti-gdf15 antibodies
07/10/2014US20140193425 Treatment of cancer with alk1 antagonists
07/10/2014US20140193422 Fully human antibodies against human 4-1bb
07/10/2014US20140193421 Anti-Human XCR1 Antibodies
07/10/2014US20140193420 Diagnosis and treatment of cancer using anti-itm2a antibody
07/10/2014US20140193419 Methods and compositions for treating and diagnosing diseases
07/10/2014US20140193418 Anti-human epo receptor antibodies and methods of use
07/10/2014US20140193417 Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy
07/10/2014US20140193416 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficle polysaccaride ps-i, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools
07/10/2014US20140193415 Bispecific anti-egfr/anti igf-1r antibodies
07/10/2014US20140193414 Anti-her antibodies
07/10/2014US20140193413 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates
07/10/2014US20140193412 Treatment of cutaneous wounds by inhibiting cold shock proteins
07/10/2014US20140193411 Multimeric constructs
07/10/2014US20140193408 Soluble proteins for use as therapeutics
07/10/2014US20140193407 Drug fusions and conjugates
07/10/2014US20140193405 Humanized anti-cd40 antibodies
07/10/2014US20140193404 Glycosylated antibodies
07/10/2014US20140193403 Epitopes of IL-17A and IL-17F and Antibodies Specific Thereto
07/10/2014US20140193402 ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF
07/10/2014US20140193401 Pertussis antibodies and uses thereof
07/10/2014US20140193400 Stable and soluble antibodies inhibiting tnf alpha
07/10/2014US20140193399 Anti-CD3 Antibodies And Methods Of Use Thereof
07/10/2014US20140193397 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
07/10/2014US20140193395 Secretory iga compositions, methods of making and methods of use thereof
07/10/2014US20140193359 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
07/10/2014US20140193333 Therapeutic and diagnostic target
07/10/2014US20140193332 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
07/10/2014US20140193329 Anti-cd151 antibodies and their use in the treatment of cancer
07/09/2014EP2752666A1 Marker for detecting colorectal cancer or esophageal cancer and method for inspecting same
07/09/2014EP2752485A1 NUCLEIC ACID CONSTRUCT INCLUDING NUCLEIC ACID DERIVED FROM GENOTYPE 3a HCV GENOME
07/09/2014EP2752428A1 Humanization of rabbit antibodies using a universal antibody framework
07/09/2014EP2752427A1 Antibodies containing therapeutic TPO/EPO mimetic peptides
07/09/2014EP2752423A2 GPCR ligands and method of using same
07/09/2014EP2752200A1 Antigen-binding molecule inducing immune response to target antigen
07/09/2014EP2751570A2 Methods and compositions for the treatment and diagnosis of cancer
07/09/2014EP2751282A1 Detection of prame gene expression in cancer
07/09/2014EP2751140A1 Anti-human xcr1 antibodies
07/09/2014EP2751139A1 Caninised tumour necrosis factor antibodies and methods of using the same
07/09/2014EP2751138A1 Viral clearance methods
07/09/2014EP2750708A1 Influenza virus antibody compositions
07/09/2014CN1795009B 抗-cd33抗体及其用途 Antibodies and their use of anti--cd33
07/09/2014CN103917650A 人源化的通用轻链小鼠 Humanized light chain mouse GM
07/09/2014CN103917563A 丝氨酸蛋白酶抑制蛋白融合多肽及其使用方法 Serine protease inhibitor protein fusion polypeptides and methods of use
07/09/2014CN103917562A 抗-ErbB3抗体及其用途 Antibodies and their use of anti--ErbB3
07/09/2014CN103917561A 肺高血压 Pulmonary hypertension
07/09/2014CN103917560A 双特异性抗-cxcr7免疫球蛋白单可变结构域 -cxcr7 Bispecific anti-immunoglobulin single variable domain
07/09/2014CN103917559A 艰难梭菌抗体 Clostridium difficile antibody
07/09/2014CN103917558A 吲哚烷基氨基-睡茄甾缀合物及其使用方法 Indole-alkyl amino - Withania steroid conjugates and methods of use
07/09/2014CN103917557A 具有降低的与抗药物抗体结合的经修饰的单可变结构域抗体 Antibody single variable domains having a reduced binding of the anti-drug antibodies modified
07/09/2014CN103917556A 抗HtrA1抗体及使用方法 Antibodies and methods of use of anti-HtrA1
07/09/2014CN103917555A 人tnf特异性的牛科动物多克隆抗体 Tnf specific person bovine polyclonal antibody
07/09/2014CN103917245A 用于制备糖-蛋白质糖缀合物的方法 Protein glycoconjugate method - for the preparation of sugar
07/09/2014CN103913576A Cystatin SN 和CA15-3在制备诊断和预示乳腺癌标志物中的应用 Cystatin SN and CA15-3 in the preparation of diagnostic markers in breast cancer and indicate the
07/09/2014CN103913574A 半胱氨酸蛋白酶抑制剂s与癌胚抗原的联合应用 Cysteine ​​protease inhibitor in combination with carcinoembryonic antigen s
07/09/2014CN103913572A 检测金黄色葡萄球菌的方法及其单抗 Detection of Staphylococcus aureus and Its Monoclonal Antibody
07/09/2014CN103911426A 半胱氨酸蛋白酶抑制剂s的应用 Application of cystatin s
07/09/2014CN103911353A 一种胰蛋白酶抑制因子单克隆抗体及其应用 One kind of trypsin inhibitor monoclonal antibody and its application
07/09/2014CN103911352A 一株能稳定分泌抗黄绿青霉素单克隆抗体的杂交瘤细胞株 Secreting a monoclonal antibody anti citreoviridin hybridoma cell lines
07/09/2014CN103911351A 分泌抗香蕉束顶病毒单抗杂交瘤细胞株及其单抗应用 Secreting monoclonal anti-BBTV monoclonal hybridoma cell line and its application
07/09/2014CN103911350A 分泌抗柑橘碎叶病毒单抗杂交瘤细胞株及其单抗应用 Secreting anti citrus tatter leaf virus monoclonal hybridoma cell lines and monoclonal Application
07/09/2014CN103911349A 分泌抗大麦黄矮病毒gav株系单抗杂交瘤细胞株及其单抗应用 Secreting anti barley yellow dwarf virus strains gav monoclonal hybridoma cell lines and monoclonal Application
07/09/2014CN103911348A 一种细胞株16号及其产生的单克隆抗体和应用 A cell monoclonal antibodies and application on the 16th and the resulting
07/09/2014CN103911347A 抗单核细胞增生李斯特菌单克隆抗体及应用 Anti-Listeria monocytogenes and application of monoclonal antibodies
07/09/2014CN103910800A 抗her2的多克隆抗体及其制备和应用 Polyclonal antibody anti-her2 its preparation and application
07/09/2014CN103910799A 一种基于抗egfr单链抗体及精氨酸九聚体的融合蛋白与应用 Application of a fusion protein and single-chain antibody and anti-egfr arginine nonamer based
07/09/2014CN103910798A 抗圆斑蝰蛇毒素和抗五步蛇毒素抗体及其制备方法和应用 Anti-viper Vipera toxin and anti-toxin antibodies acutus its preparation method and application
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 1494